东亚药业：项目结项并将节余募集资金永久补充流动资金

Group 1 - The core project names are "Research and Production Base Construction Project for Specialty New Drug Formulations (Phase I)" and "Annual Production of 3,685 tons of Pharmaceuticals and Intermediates, 4,320 tons of By-product Salts Project (Phase I)" [1] - The remaining amount of funds is 147.32 million yuan, which will be permanently used to supplement working capital for daily operations [1] - The company has completed the above fundraising projects and they have reached the intended usable status [1]